ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕

Archives

  • Home
  • Archives

Archive By Category

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Archive By Month

  • February 2026
  • November 2025
  • July 2025
  • May 2025
  • January 2025
  • September 2024
  • July 2024
  • March 2024
  • January 2024
  • October 2023
  • July 2023
  • March 2023
  • January 2023
  • September 2022
  • June 2022
  • March 2022
  • December 2021
  • September 2021
  • June 2021
  • March 2021
  • October 2020
  • June 2020
  • February 2020
  • October 2019

Archive By Tag

Advocacy Artificial intelligence (AI) Brain cancer Breast cancer ComboMATCH COVID-19 Gastrointestinal (GI) cancer Genitourinary (GU) cancer Head and neck cancer Health equity Imaging Immunotherapy In memory Leukemia Lung cancer Lymphoma Mammography Melanoma Myelodysplastic syndrome Myeloma NCI-MATCH Older adults Pancreatic cancer Pancreatic cysts Patient-reported outcomes Patient education Patient navigation Personalized treatment Precision medicine Prevention Prostate cancer Real-world data Real-world evidence Research results Sarcoma Screening for cancer Side effects Survivorship Targeted therapy Young adults


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc